8th Edition of World Congress on Infectious Diseases
June 09-11, 2025 | Rome, Italy
Market Analysis of Infectious Diseases
The global infectious disease diagnostics market is expected to rise at a CAGR of 7.2 percent from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The global incidence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early disease identification, a shift in focus from centralised laboratories to distributed POC testing, and technical improvements, are driving market expansion. Infectious disease prevalence in both established and developing nations will boost the infectious disease diagnostics market's growth. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and management of such disorders. During the projection period, these factors, combined with the growing tendency toward preventative care, are projected to increase demand for infectious disease diagnostics.
Francis J. Castellino
University of Notre Dame, United States
Stephen Hsu
Augusta University, United States
Ronald Desrosiers
University of Miami Miller School of Medicine, United States
Dong H Kwon
Long Island University, United States
Debra Hawkins
University of Oklahoma, United States
Pedro Plans Rubio
College of Physicians of Barcelona, Spain
Antonella Cardone
Cancer Patients Europe, BelgiumSubmit your abstract Today
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global climate change and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Impressive virologic suppression of SHIV infection with long-term AAV delivery of monoclonal antibodies
Ronald Desrosiers, University of Miami Miller School of Medicine, United States
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States